ReviewFrontiers in immunology2026
Mapping the immune environment: spatiotemporal dynamics in cardiovascular events.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease remains a leading cause of global mortality despite advances in revascularization, pharmacotherapy, and risk stratification. Immune responses to cardiovascular damage are neither temporally linear nor spatially homogeneous; they evolve across overlapping phases and distinct anatomical compartments. Here, we propose a four-dimensional spatiotemporal framework to map immune dynamics in cardiovascular events. Temporally, responses progress from hyperacute thrombo-inflammatory activation to acute inflammation, resolution/repair, and chronic remodeling. Spatially, immune programs differentiate across the intravascular compartment, infarct/lesion core, peri-infarct border zone, distant myocardium, and device-tissue interface, each possessing distinct cellular composition, signaling pathways, and therapeutic sensitivities. By integrating molecular imaging, single-cell and spatial transcriptomics, serial biomarker profiling, and computational modeling, we demonstrate how immune activity can be resolved with increasing anatomical and temporal precision. Using neutrophil extracellular traps as a case study, we show how the same effector mechanism can exhibit different effects depending on the phase and microenvironment. Clinical trial experience with anti-inflammatory therapies further emphasizes the need to align target selection and treatment timing with the underlying immunological trajectories. A spatiotemporal approach transforms cardiovascular inflammation from a static risk factor into a measurable and potentially targetable dynamic, site-specific process. Including phase, anatomical niche, and immune phenotype in experimental design and clinical interpretation can improve precise immunomodulation and strengthen translational alignment in cardiovascular medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.